Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label pharmacokinetic study of VENBIG and IMMUNOHBS after liver transplantation
2005-000840-10Phase 2Completed
- Sponsor
- Kedrion Biopharma
- Start
- Aug 2005
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of hepatitis B immunoglobulin in hepatitis B (HBV) (2 arms), sponsored by Kedrion Biopharma. Primary endpoints: Pharmacokinetics of VENBIG and Pharmacokinetics of IMMUNOHBS. Started Aug 2005; status: completed.
02
Drugs
hepatitis B immunoglobulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2005-000840-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000840-10.